MKI67 and glioblastoma: FK506 is capable of reversing this mechanism, as the treatment of FK506 in combination with Vc showed, reducing tumor volume as well as reducing GFAP, nestin, and Ki67 levels, which are associated with GBM aggressiveness [35,36].